The novel fusion protein CD160IG prevents skin and cardiac allograft rejection.

被引：0
|
作者：
Habicht, A
Ansari, JI
Clarkson, MR
Ueno, T
Yuan, X
Fernandes, SM
Freeman, GJ
Sayegh, MH
机构：
[1] Brigham & Womens Hosp, Transplant Res Ctr, Boston, MA 02115 USA
[2] Childrens Hosp, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
875
引用
收藏
页码：379 / 379
页数：1
相关论文
共 50 条
  • [31] VLA-4/VCAM-1 Interactions Are Required for Endogenous Memory CD8 T Cell Mediated Cardiac Allograft Rejection.
    Iida, S.
    Su, C.
    Abe, T.
    Kish, D.
    Kohei, N.
    Baldwin, W., III
    Tanabe, K.
    Fairchild, R.
    TRANSPLANTATION, 2014, 98 : 322 - 322
  • [32] A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy
    Yuan, Xueli
    Paez-Cortez, Jesus
    Schmitt-Knosalla, Isabela
    D'Addio, Francesca
    Mfarrej, Bechara
    Donnarumma, Michela
    Habicht, Antje
    Clarkson, Michael R.
    Iacomini, John
    Glimcher, Laurie H.
    Sayegh, Mohamed H.
    Ansari, M. Javeed
    JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (13): : 3133 - 3144
  • [33] LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model
    Zhou, DJ
    O'Brien, C
    Shum, J
    Garciz, B
    Min, WP
    Jevnikar, AM
    Dutartre, P
    Zhong, R
    TRANSPLANTATION, 2003, 76 (04) : 644 - 650
  • [34] A novel anti-CD40 antibody prevents activation of alloreactive T cells and prolongs skin allograft survival
    Jangalwe, Sonal N.
    Ralph, Kerry
    Ramanujam, Meera
    Greiner, Dale L.
    Brehm, Michael A.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [35] Allograft TLR9 is Required for Endogenous Donor-Reactive Memory CD8 T Cell Activation in High-Risk Cardiac Allografts to Mediate CTLA-4Ig Resistant Graft Rejection.
    Koritzinsky, E. H.
    Ueda, D.
    Tsuda, H.
    Miyari, S.
    Fairchild, R. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 415 - 416
  • [36] DUAL AND OPPOSITE COSTIMULATORY TARGETING WITH A NOVEL HUMAN RECOMBINANT PROTEIN PREVENTS RENAL WARM IRI AND ALLOGRAFT REJECTION IN MURINE MODELS
    Guiteras, Jordi
    Crespo, Elena
    Bolanos, Nuria
    Barcelo, Silvia
    Martinez-Valenzuela, Laura
    Fontova, Pere
    Torija, Alba
    Bestard, Oriol
    Resina, David
    Grinyo, Josep M.
    Torras, Joan
    TRANSPLANT INTERNATIONAL, 2021, 34 : 272 - 272
  • [37] The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates
    Oshima, Shinsuke
    Karrer, Erik E.
    Kawato, Yuka
    Maeda, Masashi
    Fukahori, Hidehiko
    Tsujimoto, Susumu
    Hirose, Jun
    Nakamura, Koji
    Marui, Takanori
    Takamura, Fujiko
    Noto, Takahisa
    Chapin, Steven J.
    Fujii, Yasutomo
    Neighbors, Margaret
    Viswanathan, Sridhar
    Devens, Bruce H.
    Higashi, Yasuyuki
    TRANSPLANTATION, 2016, 100 (12) : 2611 - 2620
  • [38] Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats
    Simeoni, Eleonora
    Dudler, Jean
    Fleury, Sylvain
    Li, Jianping
    Pagnotta, Maria
    Pascual, Manuel
    von Segesser, Ludwig K.
    Vassalli, Giuseppe
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 31 (02) : 222 - 228
  • [39] Prolongation of renal allograft survival with blockade of the CD28 pathway using a novel mutant CTLA4-Ig fusion protein in non-human primates.
    Pearson, TC
    Lin, A
    Odom, K
    Cowan, S
    Peach, R
    Haggerty, D
    Larsen, CP
    TRANSPLANTATION, 2000, 69 (08) : S123 - S123
  • [40] Human membrane cofactor protein (CD46) prevents hyperacute xenograft rejection in porcine-to-baboon cardiac xenotransplantation
    Lawson, JH
    Diamond, LE
    Lin, SS
    Hoopes, CW
    Daniels, LJ
    Morowitz, MJ
    Kalady, MK
    Martin, MJ
    Davis, RD
    Logan, JS
    Platt, JL
    CIRCULATION, 1997, 96 (08) : 3167 - 3167
12345